Drug:
Reaction: ERYTHEMA
20250101 - 20251231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 25095118 |
CA |
30 | 2 |
Swollen tongue, Dyspnoea, Pruritus, Erythema, Hemiplegic migraine, Throat irritation, Throat tightness, Fatigue, |
||||
EPTINEZUMAB-JJMR, |
||||
| 302 | 25095155 |
US |
||
Erythema, Skin irritation, |
||||
ADAPALENE, |
||||
| 303 | 25095163 |
US |
||
Skin burning sensation, Hypersensitivity, Erythema, Acne, Rash papular, Urticaria, Erythema, |
||||
ADAPALENE, |
||||
| 304 | 25095177 |
US |
||
Erythema, Pain of skin, |
||||
ADAPALENE, |
||||
| 305 | 25095178 |
US |
||
Condition aggravated, Erythema, Rash, Rash papular, Fear, Skin burning sensation, Skin irritation, Drug ineffective, |
||||
ADAPALENE, |
||||
| 306 | 25095179 |
US |
||
Dry skin, Skin burning sensation, Pain of skin, Erythema, |
||||
ADAPALENE, |
||||
| 307 | 25095191 |
US |
||
Photosensitivity reaction, Skin exfoliation, Dry skin, Erythema, Acne, |
||||
| 308 | 25095203 |
US |
||
Periorbital swelling, Hypersensitivity, Erythema, Pain of skin, Rash, |
||||
ADAPALENE, AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, |
||||
| 309 | 25095209 |
US |
||
Dry skin, Erythema, |
||||
ADAPALENE, |
||||
| 310 | 25095213 |
US |
||
Pain of skin, Erythema, |
||||
ADAPALENE, |
||||
| 311 | 25095222 |
US |
||
Headache, Skin burning sensation, Erythema, Skin swelling, Skin exfoliation, Gait disturbance, Pain, Pruritus, Sensitive skin, Swelling face, Cushingoid, Oral discomfort, |
||||
| 312 | 25095230 |
US |
||
Erythema, Condition aggravated, Rash papular, Drug ineffective, |
||||
ADAPALENE, AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, SULFUR, SALICYLIC ACID, |
||||
| 313 | 25095235 |
US |
||
Erythema, Hypersensitivity, Swelling face, |
||||
ADAPALENE, AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, |
||||
| 314 | 25095236 |
US |
||
Hypersensitivity, Acne, Pruritus, Erythema, Drug ineffective, Inappropriate schedule of product administration, Underdose, |
||||
ADAPALENE, |
||||
| 315 | 25095238 |
US |
||
Erythema, Pain of skin, Acne, Drug ineffective, |
||||
ADAPALENE, |
||||
| 316 | 25095241 |
US |
||
Erythema, Dry skin, Skin burning sensation, Acne, Product use issue, |
||||
ADAPALENE, GUANFACINE, GUANFACINE HYDROCHLORIDE, GAUNFACINE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 317 | 25095243 |
US |
||
Skin burning sensation, Erythema, |
||||
ADAPALENE, |
||||
| 318 | 25095257 |
US |
||
Hypersensitivity, Skin swelling, Urticaria, Erythema, Skin swelling, |
||||
ADAPALENE, |
||||
| 319 | 25095259 |
US |
||
Dry skin, Skin burning sensation, Erythema, Skin exfoliation, Pain of skin, Inappropriate schedule of product administration, Overdose, |
||||
ADAPALENE, ADAPALENE, AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, |
||||
| 320 | 25095260 |
US |
||
Dry skin, Acne, Erythema, Pain of skin, Skin fissures, Drug ineffective, |
||||
ADAPALENE, |
||||
| 321 | 25095267 |
US |
||
Dermatitis, Erythema, Inappropriate schedule of product administration, Underdose, |
||||
ADAPALENE, SALICYLIC ACID, |
||||
| 322 | 25095352 |
IN |
48 | 2 |
Pyloric stenosis, Cardiac ventricular thrombosis, Oesophageal candidiasis, Arteriovenous fistula thrombosis, Erythema, Furuncle, Pain, Vomiting, Diarrhoea, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 323 | 25095433 |
CN |
1 | |
Mouth haemorrhage, Haemarthrosis, Gastrointestinal haemorrhage, Abdominal pain, Anti factor VIII antibody increased, Haemorrhage, Vomiting, Arthralgia, Joint swelling, Erythema, Physical disability, Heart rate increased, Palpitations, Pain, |
||||
| 324 | 25095498 |
US |
1 | |
Fatigue, Discomfort, Erythema, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 325 | 25095722 |
US |
23 | 2 |
Erythema, Pruritus, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 326 | 25095796 |
GB |
45 | 2 |
Swelling, Erythema, |
||||
METHOTREXATE SODIUM, |
||||
| 327 | 25095945 |
US |
32 | 2 |
Psoriasis, Pruritus, Erythema, Burning sensation, |
||||
LEVONORGESTREL, |
||||
| 328 | 25096111 |
PT |
76 | 1 |
Neuropathy peripheral, Neutropenia, Acute kidney injury, Respiratory failure, Cardiac failure, Rectal haemorrhage, Haemorrhoidal haemorrhage, Atrial fibrillation, Hyperglycaemia, Dry skin, Skin exfoliation, Erythema, Decreased appetite, Weight decreased, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, APIXABAN, BISOPROLOL FUMARATE, ROSUVASTATIN, |
||||
| 329 | 25096131 |
SI |
66 | 1 |
Oxygen saturation decreased, Hypotension, Pruritus, Erythema, Heart rate increased, |
||||
IOPROMIDE, |
||||
| 330 | 25096147 |
US |
2 | |
Erythema, Abdominal distension, Ascites, Hepatomegaly, Hepatic steatosis, Cardiac disorder, Liver disorder, Product storage error, |
||||
METRELEPTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CYCLOSPORINE, FENOFIBRATE, BACTERIOSTATIC WATER, AMIODARONE HYDROCHLORIDE, FUROSEMIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, NORTRIPTYLINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, |
||||
| 331 | 25096169 |
BR |
8 | 2 |
Erythema, Cough, Nausea, Respiratory disorder, Syncope, |
||||
GADOBUTROL, |
||||
| 332 | 25096373 |
CN |
54 | 2 |
Eczema, Skin ulcer, Erythema, Papule, Hyperkeratosis, Skin fissures, Dry skin, Skin weeping, |
||||
SECUKINUMAB, |
||||
| 333 | 25096745 |
US |
33 | 1 |
Eczema, Erythema, Dry skin, |
||||
DUPILUMAB, |
||||
| 334 | 25096864 |
US |
32 | 1 |
Application site erythema, Rash, Burning sensation, Erythema, Dermatitis atopic, Intertrigo, Rash, |
||||
| 335 | 25086728 |
US |
67 | 2 |
Anorectal disorder, Genital tract inflammation, Erythema, Genital erythema, Proctalgia, Genital pain, |
||||
EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, |
||||
| 336 | 25086983 |
CO |
78 | 2 |
Deafness, Tachycardia, Feeling hot, Hyperhidrosis, Erythema, |
||||
INSULIN DEGLUDEC, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, INSULIN GLULISINE, |
||||
| 337 | 25087078 |
US |
1 | |
Muscle spasms, Erythema, |
||||
GUSELKUMAB, |
||||
| 338 | 25087182 |
US |
||
Pruritus, Erythema, Urticaria, Drug hypersensitivity, Off label use, Product prescribing issue, Skin atrophy, Rash, |
||||
ROSUVASTATIN, |
||||
| 339 | 25087219 |
US |
||
Erythema, Pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 340 | 25087634 |
US |
44 | 1 |
Erythema, Pruritus, |
||||
GUSELKUMAB, |
||||
| 341 | 25087771 |
IT |
65 | 1 |
Erythema, Chest discomfort, Transfusion-associated dyspnoea, |
||||
NIVOLUMAB, |
||||
| 342 | 25088487 |
JP |
1 | |
Myelosuppression, Platelet count decreased, Rash, Erythema, |
||||
AMIVANTAMAB, |
||||
| 343 | 25088651 |
CO |
2 | |
Erythema, Pyrexia, Posture abnormal, Eye movement disorder, |
||||
PALIVIZUMAB, |
||||
| 344 | 25089145 |
ES |
64 | 2 |
Heart failure with reduced ejection fraction, Cardiomyopathy, Mitral valve incompetence, Atrial fibrillation, Bundle branch block left, Sinus node dysfunction, Erythema, Contusion, Pain in extremity, Muscle spasms, Abdominal pain, Diarrhoea, Nausea, Vertigo, Block vertebra, Headache, Migraine, |
||||
SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LANSOPRAZOLE, |
||||
| 345 | 25089159 |
PL |
76 | 1 |
Cutaneous T-cell lymphoma, Dermatitis exfoliative generalised, Condition aggravated, Face oedema, Oedema peripheral, Cutaneous symptom, Erythema, Skin lesion, Xerosis, Lichenification, Leukocytosis, Lymphocytosis, Skin plaque, Lymphocytic infiltration, Abscess, |
||||
DUPILUMAB, DEFLAZACORT, DEFLAZACORT, |
||||
| 346 | 25089641 |
FR |
2 | |
Erythema, |
||||
CARBOPLATIN, PACLITAXEL, DOSTARLIMAB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, APREPITANT, METHYLPREDNISOLONE, |
||||
| 347 | 25090392 |
US |
39 | 1 |
Skin burning sensation, Erythema, Pruritus, |
||||
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, |
||||
| 348 | 25090926 |
CA |
75 | 2 |
Erythema, Product quality issue, Pruritus, Type IV hypersensitivity reaction, Urticaria, Product use in unapproved indication, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, |
||||
| 349 | 25090952 |
PT |
55 | 2 |
Generalised oedema, Eyelid oedema, Erythema, Dermatitis allergic, |
||||
TERBINAFINE HYDROCHLORIDE, TERBINAFINE, SERTACONAZOLE NITRATE, |
||||
| 350 | 25090984 |
CA |
50 | 2 |
Infusion related reaction, Middle insomnia, Dermatitis contact, Muscular weakness, Asthenia, Rash, Burning sensation, Erythema, Infusion site swelling, Tremor, Fatigue, Infusion site erythema, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ESTRADIOL, VORTIOXETINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ERGOCALCIFEROL, HYDROXYCHLOROQUINE, PROGESTERONE, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS), |
||||
| 351 | 25091005 |
CA |
60 | 2 |
Blood pressure abnormal, Inappropriate schedule of product administration, Nasopharyngitis, Infusion related reaction, Device difficult to use, Abdominal distension, Infusion site bruising, Erythema, |
||||
BENRALIZUMAB, TIOTROPIUM BROMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, MOMETASONE, |
||||
| 352 | 25091019 |
CA |
77 | 2 |
Infusion site erythema, Infusion site discomfort, Arthritis, Infusion related reaction, Eye swelling, Infusion site swelling, Weight increased, Heart rate increased, Thyroid hormones decreased, Injection site erythema, Peripheral swelling, Joint swelling, Swelling face, Pruritus, Burning sensation, Diarrhoea, Dizziness, Blood pressure increased, Erythema, Fatigue, Headache, Product preparation issue, Product use issue, |
||||
BENRALIZUMAB, RABEPRAZOLE, LEVOTHYROXINE SODIUM, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL, IPRATROPIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, |
||||
| 353 | 25091056 |
ES |
89 | 1 |
Pruritus, Erythema, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 354 | 25091080 |
CA |
46 | 2 |
Infusion site erythema, Infusion site pruritus, Dermatitis contact, Product storage error, Infusion site dryness, Feeling abnormal, Influenza, Inappropriate schedule of product administration, Sinusitis, Abdominal discomfort, Blood pressure decreased, Malaise, Pruritus, Fatigue, Vomiting, Lethargy, Erythema, Infusion site induration, Infusion site pain, |
||||
LANSOPRAZOLE, ERGOCALCIFEROL, VITAMIN C, IRON, |
||||
| 355 | 25091312 |
US |
2 | |
Erythema, |
||||
DUPILUMAB, UPADACITINIB, |
||||
| 356 | 25091408 |
US |
56 | 2 |
Pruritus, Erythema, Injection site bruising, |
||||
DUPILUMAB, ESCITALOPRAM, PHENTERMINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LISINOPRIL, |
||||
| 357 | 25091478 |
US |
12 | 2 |
Rash, Erythema, Swelling face, |
||||
DUPILUMAB, |
||||
| 358 | 25091482 |
US |
1 | |
Erythema of eyelid, Therapeutic response shortened, Erythema, Eczema, Rash, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 359 | 25091497 |
US |
26 | 1 |
Emotional distress, Depressed mood, Periorbital swelling, Erythema, Back pain, Arthralgia, Pain in extremity, Therapeutic product effect decreased, |
||||
DUPILUMAB, |
||||
| 360 | 25091554 |
US |
14 | 1 |
Burning sensation, Pruritus, Erythema of eyelid, Erythema, Injection site pain, |
||||
DUPILUMAB, |
||||
| 361 | 25091595 |
US |
8 | 1 |
Insomnia, Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 362 | 25091647 |
US |
37 | 2 |
Dermatitis atopic, Erythema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 363 | 25091689 |
US |
1 | |
Erythema, Seasonal allergy, |
||||
DUPILUMAB, |
||||
| 364 | 25091710 |
US |
24 | 1 |
Allergy to chemicals, Erythema, Rash, |
||||
DUPILUMAB, |
||||
| 365 | 25091735 |
US |
51 | 2 |
Dermatitis atopic, Rash, Pruritus, Erythema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 366 | 25091746 |
US |
65 | 1 |
Rash, Erythema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 367 | 25091886 |
US |
48 | 2 |
Drug delivery system malfunction, Device occlusion, Chest pain, Erythema, Feeling hot, Cyst, Product administration interrupted, Underdose, |
||||
EPOPROSTENOL, MACITENTAN, |
||||
| 368 | 25094481 |
42 | 2 | |
Ear pain, Discomfort, Erythema, Ear infection, Drug hypersensitivity, Impaired work ability, |
||||
| 369 | 25094819 |
59 | 2 | |
Flushing, Ephelides, Erythema, Feeling hot, |
||||
ROSUVASTATIN, |
||||
| 370 | 25081773 |
ES |
||
Suicide attempt, Drug ineffective, Depression, Somnolence, Blood pressure increased, Dissociation, Vision blurred, Depersonalisation/derealisation disorder, Erythema, Dysgeusia, Vomiting, Dizziness, Paraesthesia, Treatment noncompliance, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 371 | 25081894 |
US |
13 | 1 |
Injection site erythema, Sneezing, Superficial injury of eye, Ocular hyperaemia, Eye pruritus, Eczema, Skin swelling, Erythema, Product prescribing issue, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 372 | 25081989 |
GB |
14 | 1 |
Respiratory distress, Cough, Anaphylactic reaction, Erythema, |
||||
| 373 | 25082013 |
US |
5 | 2 |
Erythema, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 374 | 25082021 |
US |
61 | 2 |
Ocular hyperaemia, Eczema, Skin swelling, Erythema, Pruritus, Injection site erythema, Injection site pruritus, Eye pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 375 | 25082057 |
US |
2 | |
Pruritus, Erythema, |
||||
OCRELIZUMAB, |
||||
| 376 | 25082185 |
US |
68 | 2 |
Memory impairment, Thirst, Pruritus, Erythema, Somnolence, Fatigue, Asthenia, Decreased appetite, Blood glucose increased, Alopecia, |
||||
BEVACIZUMAB-AWWB, BEVACIZUMAB, PEMBROLIZUMAB, PACLITAXEL, CARBOPLATIN, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, CETIRIZINE HYDROCHLORIDE, FAMOTIDINE, |
||||
| 377 | 25082201 |
US |
2 | |
Erythema, Insomnia, Inappropriate schedule of product administration, |
||||
DUPILUMAB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, |
||||
| 378 | 25082255 |
US |
1 | |
Erythema, Pruritus, Skin burning sensation, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 379 | 25082483 |
US |
1 | |
Rash vesicular, Pruritus, Urticaria, Erythema, |
||||
EVOLOCUMAB, EVOLOCUMAB, ROSUVASTATIN, |
||||
| 380 | 25082568 |
GB |
||
Erythema, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 381 | 25082646 |
US |
15 | 1 |
Myalgia, Erythema, Swelling, Inflammation, |
||||
GIVINOSTAT, VILTOLARSEN, TESTOSTERONE, TESTOSTERONE,, |
||||
| 382 | 25082686 |
US |
41 | 1 |
Erythema, Pruritus, Dry eye, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 383 | 25082855 |
US |
50 | 2 |
Pruritus, Rash, Erythema, Eye pruritus, Paraesthesia, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 384 | 25082878 |
US |
2 | |
Abdominal discomfort, Erythema, |
||||
DUPILUMAB, |
||||
| 385 | 25083245 |
GB |
79 | 1 |
Joint swelling, Erythema, |
||||
AMLODIPINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, MESALAMINE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, |
||||
| 386 | 25083298 |
US |
1 | |
Erythema, Dry skin, Therapeutic response shortened, Product prescribing issue, |
||||
DUPILUMAB, |
||||
| 387 | 25083436 |
US |
86 | 1 |
Bone pain, Chest discomfort, Pyrexia, Erythema, Pruritus, Fatigue, Chest pain, |
||||
PACRITINIB, |
||||
| 388 | 25083503 |
US |
2 | |
Dermatitis atopic, Erythema, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 389 | 25083711 |
ES |
||
Erythema, Pruritus, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 390 | 25083901 |
JP |
24 | 2 |
Erythema, |
||||
| 391 | 25083938 |
US |
29 | 2 |
Rash, Erythema, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 392 | 25083972 |
US |
2 | |
Erythema, |
||||
ETANERCEPT, |
||||
| 393 | 25084485 |
US |
80 | 2 |
Discomfort, Dry skin, Pain, Erythema, Rash, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
| 394 | 25084902 |
GB |
62 | |
Erythema, Wheezing, Cough, Hypertension, |
||||
RAVULIZUMAB, FOLIC ACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 395 | 25085272 |
FR |
68 | 1 |
Erythema, Bronchospasm, Palmar erythema, |
||||
PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, AMIVANTAMAB, |
||||
| 396 | 25085552 |
IT |
86 | 2 |
Rash maculo-papular, Nausea, Erythema, Decreased appetite, |
||||
ALLOPURINOL, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, LINAGLIPTIN, OLMESARTAN MEDOXOMIL, |
||||
| 397 | 25085577 |
|||
Erythema, Erythema, Pruritus, Infusion related reaction, |
||||
| 398 | 25085583 |
BR |
65 | |
Endocarditis bacterial, Mitral valve incompetence, Osteonecrosis, Toothache, Wisdom teeth removal, Pain in jaw, Swelling, Abscess drainage, Erythema, Post procedural infection, Disease progression, Tooth abscess, |
||||
FULVESTRANT, FULVESTRANT, ATENOLOL, CEPHALEXIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PREDNISONE, |
||||
| 399 | 25085587 |
CA |
71 | 2 |
Chronic sinusitis, Anaemia, Colitis, Colitis ulcerative, Abdominal pain, Constipation, Dyspepsia, Erythema, Female genital tract fistula, Frequent bowel movements, Haematochezia, Headache, Macular degeneration, Malaise, Nausea, Oral candidiasis, Pain, Paraesthesia oral, Procedural pain, Proctitis, Pyrexia, Radiculopathy, Rectal haemorrhage, Vaginal discharge, Vaginal flatulence, Weight decreased, Infusion related reaction, Off label use, Drug ineffective, Therapeutic product effect incomplete, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, AMOXICILLIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN DIHYDRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, HYDROCHLOROTHIAZIDE, HYDROMORPHONE HYDROCHLORIDE, PREGABALIN, ATROPINE SULFATE, ATROPINE SULFATE MONOHYDRATE, ATROPINE SULFATE INJECTION, FLUTICASONE FUROATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CLARITHROMYCIN, CALCIUM, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, CITRIC ACID, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, HYDROCORTISONE, CUPRIC OXIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DESONIDE, DEXPANTHENOL, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, DIMETHYL SULFOXIDE, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, VEDOLIZUMAB, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, FENTANYL CITRATE, FENTANYL CITRATE, FLUCONAZOLE, FLUCONAZOLE, METRONIDAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, NITROGLYCERIN, GLYCERIN, GLYCERIN SUPPOSITORY, GLYCERIN, GLYCERIN SUPPOSITORY, GLYCERIN, GLYCERIN SUPPOSITORY, GLYCERIN, GLYCERIN SUPPOSITORY, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, NICOTINE TRANSDERMAL SYSTEM PATCH, ADALIMUMAB, ADALIMUMAB, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCORTISONE BUTYRATE, INFLIXIMAB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ISONIAZID, ISONIAZID, KENALOG, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, METHOTREXATE, METHOTREXATE SODIUM, MIDAZOLAM HYDROCHLORIDE, MORPHINE SULFATE, MAGNESIUM CARBONATE, MAGNESIUM OXIDE, MESALAMINE, MESALAMINE, MESALAMINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METOCLOPRAMIDE HYDROCHLORIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MORPHINE, MORPHINE, POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE, MORPHINE SULFATE, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN CALCIUM, NITROGLYCERIN, NADOLOL, NADOLOL, NEOMYCIN SULFATE, NICOTINE, NICOTINE, NICOTINAMIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE, PANTOPRAZOLE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREGABALIN, PREGABALIN, MESALAMINE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, POLYMYXIN B SULFATE, POLYMYXIN B SULFATE, PREDNISONE, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, INFLIXIMAB, INFLIXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MESALAMINE, MESALAMINE, SIMVASTATIN, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, MORPHINE SULFATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIMETHOPRIM, VALSARTAN, VALSARTAN, VALSARTAN, VALSARTAN, VEDOLIZUMAB, VEDOLIZUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, VITAMIN E, CREAM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ZINC CHLORIDE, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 400 | 25085767 |
FR |
||
Hypersensitivity, Dyspnoea, Oedema mouth, Pruritus, Hypersensitivity, Erythema, Pruritus, Dysphagia, |
||||
OFATUMUMAB, OFATUMUMAB, GABAPENTIN, DALFAMPRIDINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28